ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 19 filers reported holding ARCA BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $163,000 | -63.5% | 326,147 | +0.4% | 0.00% | -66.7% |
Q4 2017 | $447,000 | +73.3% | 324,847 | +38.3% | 0.00% | +50.0% |
Q3 2017 | $258,000 | -41.5% | 234,847 | +30.6% | 0.00% | -33.3% |
Q2 2017 | $441,000 | +465.4% | 179,847 | +476.4% | 0.00% | +200.0% |
Q1 2017 | $78,000 | -78.5% | 31,200 | -75.2% | 0.00% | -50.0% |
Q3 2016 | $363,000 | -18.1% | 125,733 | -17.7% | 0.00% | -33.3% |
Q2 2016 | $443,000 | -28.2% | 152,733 | -15.0% | 0.00% | -25.0% |
Q1 2016 | $617,000 | – | 179,757 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 1,460,209 | $3,505,000 | 0.13% |
Aveo Capital Partners, LLC | 93,667 | $225,000 | 0.08% |
Tekla Capital Management LLC | 811,227 | $1,988,000 | 0.07% |
ROYCE & ASSOCIATES LP | 179,847 | $441,000 | 0.00% |
FRANKLIN RESOURCES INC | 1,216,840 | $2,981,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 576 | $1,000 | 0.00% |
NORTHERN TRUST CORP | 11,018 | $26,000 | 0.00% |
DEUTSCHE BANK AG\ | 60,308 | $144,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 16,181 | $39,000 | 0.00% |
MORGAN STANLEY | 243 | $1,000 | 0.00% |